Stella Hughes

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

Tomáš Kalinčík, Ibrahima Diouf, Sifat Sharmin et al. · Neurology · 2020 · 87 citations · Full text

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Izanne Roos, Stella Hughes, Gavin McDonnell et al. · JAMA Neurology · 2023 · 55 citations · Full text

COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies

Afagh Garjani, Rod Middleton, Rachael Hunter et al. · Multiple Sclerosis and Related Disorders · 2021 · 52 citations · Full text

Autoimmune Disease, Neurological Disorder, Medicine +10

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.

Stella Hughes, Timothy Spelman, María Trojano · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · 2012 · 43 citations

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Alessio Signori, Guillermo Izquierdo, Alessandra Lugaresi et al. · Multiple Sclerosis Journal · 2017 · 43 citations